ArticleExpert review of hematology2013

Higher-risk myelodysplastic syndromes with del(5q): is sequential azacitidine-lenalidomide combination the way to go?

Amer M Zeidan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.